(nNOS)onperivascularnitrergicneuronskeepocularblood circulationandpreventsinfarct [1] [2] [3] . Moreover,itwasrevealedthathypertensionactivatesET-1 signalingpathwayintrabecularmeshwork(TM).The increaseofET-1andeNOShasreachedtheirpeakinthe secondweekofhypertensionrelatedtoET-1receptorA (ETR A )andET-1receptorB (ETR B )expressionasET-1 receptors.Otherstudyresultsshowedthepossibilityof hypertensioneffectedonNTGoccurrenceandprolonged retinalarteriovenouspassage(AVP)time [4] [5] . [11, 14, 16] .
Hypertension Effect on Intraocular Pressure
HypertensioneffectsofDOCA-saltmodelonTMwere allegedduetotheincreasedglucocorticoidreceptor(GR). Sharif [17] mentionedthattheeffectofrenin-angitensin(RAS) onTMwasshowninangiotensinreceptor1(ATR1)activity thatmediatedsignalingfortheaccumulationofextracellular matrixandTGF-茁 onTMtissuethatleadsincreaseofIOP. Stokes [18] hasfoundthehighexpressionofGRmRNA andmineralocorticoid11茁-HSDthatinteractwithMRwhich hasaroleinthemechanismofionandwatertransport, includingthesecretionofaqueoushumor(AH).Alsoknown thatMRonTMiswell-bondedwithcortisolandaldosterone. Mineralocorticoideffectsoneyesweremediatedbyepithelial sodiumchannels(EnaC),whichinvolvedintheincreasingof AHformationandorganizeTMresistancethroughthe regulationofTMcellvolume [17] [18] [19] (Figure9). ThepreviousstudyreportedthatATR1antagonist(losartan andolmesartanmedoxomil),angiotensin-convertingenzyme (ACE) inhibitors(enalapril),andrenininhibitors (CGP38650,SRO43845andAbbott-64662)coulddecrease IOPby15%-20%bothinanimalandhumanmodels. Vaajanen [11] reportedthattopicaldiminazeneaceturate (DIZE)administrationasACE-2activatorcouldreduceIOP inrabbiteyes.ResearchbyFoureaux [20] foundthat 1mg/kgofDIZEdailyoraladministrationfor1mocould increasetheACE-2expressionintheretina.Hypotension effectsofDIZEcouldbepreventedbyadministrationof Mas-receptor-selectiveantagonistA-779.Thiscondition indicatedDIZEhashelpedAng(1-7)inMas-receptor activationtodecreaseIOP.ItwasfurtherstatedthatAH drainagefromanteriorcameraoculiwasstimulatedbyDIZE. RGCwasmaintainedbyDIZEthroughinhibitionofcaspase 3expressions.Meanwhile,Agarwal [21] foundthatACE inhibitorcouldinducethedecreasingofIOPthroughits involvementinMMPsandcytokinesmodulation.Research byVaajanen [22] foundthattheadministrationof enalaprilatdehydrates1%(ACEinhibitor)singledropcould reduceIOPby20.3%after3hofadministrationwhile losartanpotassium2%(ATR1blocker)administrationcould decreasetheIOPby13.3% [11, [20] [21] [22] [23] .
Figure9HypothesisoftheinvolvementofRASsystemand activationofET-1signalingpathwayonIOPelevationin mice [17] ThisfigureshowsAng-I,Ang-II,andAng(1-7)production andtheirpreferredreceptorsubtypeMas-1andAT-1receptors mediatesignalingforactivationofMLCKthatresponsiblefor raisingIOP.Ang:Angiotensin;ATR1:Angiotensinreceptor1;IOP: Intraocularpressure;RAS:Renin-angitensin. studyrevealedthat DOCA-salthypertensionmodelhasseveraldevelopmental phases.Inseconduntilthesixthweekofdevelopmental phase,theactivityofsympathicandhumoralarebalance indicatedbytheincreasingofVasopressin(VP)danET-1 [6, [24] [25] .
TheincreasingofET-1expressioninthisstudysuspectedas theresultofET-1localizationinCRAendothelialcells occursduetoautoregulationdysfunctionandmechanical compression.Thepreviousstudyreportsthatendothelialcell willexpresstheET-1ascentralbaroreceptor-responsiveand havearoleinchoroidalregulationagainsthighsystemic SBP.Inthisstudy,theadministrationofDOCA-saltcauses ischemiaintheCRAsmoothmuscle,probablyby1) involvementofaldosteroneinincreasingtheactivityofMR thatincreasesNADPHoxidaseandreleaseofNO;2) activationofsympatheticinnervationinthechoroidwhich increasesIOP,destructionofbloodretinalbarrier(BRB)and releaseofET-1.TheimbalanceofET-1andNOistheinitial processofendothelialdysfunctionintheCRA [26] [27] . [30] . EffectofHypertensiononPhosphorylatedMyosinLight ChainKinaseandCaldesmonExpression Actin-myosin interactioninmolecularleveliscontrolledby2isoformsof myosinII.Theseisoformsactivitiesaredeterminedby phosphorylationofposttranslationalmyosinregulatorylight chain9(Myl9)throughantagonistactivityofMLCKand myosinlightchain(MLC)phosphatase(MYP).Post-translation modificationofMyl9istriggeredbyRhoA/ROCKsignaling pathwayenhancedbyMLCphosphorylationthroughMyosin LightChainPhosphorylation(MLCP)inhibitiononporcine retinalartery [23] .MLCKactivationsignificantlyincreasedon CRAsmoothmusclein2-weekgroup(1190.09依58.32Au)and 6-weekgroup(875.69依9.53Au)comparedtocontrolgroup, whilethereisnosignificantdifferencebetween10-week group(779.77依8.52Au)andcontrol(765.73依12.26Au). StudyofLicht [31] showthatDOCA-salthypertension inductionwithsubcutaneousinjectionof50mgpelletfor21d causesarteriolarvasoconstrictiononretina.Italsoincreases expressionofMyl9andphosphorylatedMyl9levelinsmooth musclecellsofretinalvascular.Thisconditionisrelatedto ET-1whichinducedbyactivatorprotein-1(AP-1)asa transcriptionfactorofcellularcontractility,vascularsmooth musclemigration, proliferationduringneointimal formation,andendothelialcellmigrationanddevelopment. ET-1alsostimulatedERKactivityandfurtherAP-1 activities.Myl9upregulationisaresponseofvascularsmooth muscleonstress [32] . PhosphorylatedCaDexpressioninCRAsmoothmusclecells significantlyincreasedinallhypertensionmodelgroups comparedtocontrol(882.04依9.73Au).Itdecreasedsignificantly onthesixthweekofhypertension(1273.10 依8.81Au)and increasedagainonthetenthweek(1375.45 依9.14Au)but lowerthanthesecondweek(1670.28依18.36Au).Durationof CaDactivationislongerthanMLCKactivation [33] . 
